Punjab Chemicals & Crop Protection Ltd. · NSE:PUNJABCHEM

Punjab Chemicals & Crop Protection — Q3 FY21 Earnings Presentation

15 slides from Punjab Chemicals & Crop Protection's earnings presentation, Jan 29, 2021

  1. Slide 1: Investor Presentation filing letter to stock exchanges

    PUI.\UAB CHEMICALS AND CROP PROTECTION LTD c rN No. L24231PA1975P LC047063 Regd. Oflice & Works Milestone-l8,Ambala-Kalka Road, Village & P.O. Bhankharpur, Derabassi, Distt SAS Nagar, Mohali (punjab)-l4020l,IND1A Tele:01762-280086, 522250,Fax: 01762-280070, E-mail: info@punjabchemicals.com, Website:

  2. Slide 2: Q3 & 9M FY21 Result Presentation

    Q3 & 9M FY21 Result Presentation

  3. Slide 3: Disclaimer

    Disclaimer  This presentation and the following discussion may contain “forward looking statements” by Punjab Chemicals & Crop Protection Limited (“Punjab Chemicals” or the Company) that are not historical in nature. These forward looking statements, which may include statements relating to future

  4. Slide 4: Discussion Summary

    DISCUSSION SUMMARY Company Overview Milestones Business Strategy Business Update Financial Overview – Q3 & 9M FY21 Past Performance At a Glace 3

  5. Slide 5: Company Overview

    COMPANY OVERVIEW About Us Our Mission • Established in 1975 • To meet the customer expectations with • Specialising in agrochemicals products of the right quality • Expanding aggressively in contract research & manufacturing (CRAMS) • To focus on products and companies which ensure better added valu

  6. Slide 6: Milestones Achieved

    MILESTONES ACHIEVED 2021 Debt Reduction – ₹30 cr Business Model - Contract Manufacturing 2016 M&A - Alpha Drug Pharma 2003 2018 Capacity enhancement – Agrochemicals Diversification- Specialty Chemicals 1983 2006 Integration under one umbrella- Punjab Chemicals 1995 Diversification- Agrochemicals 197

  7. Slide 7: Business Strategy

    BUSINESS STRATEGY Identify Niche Partner for Modus Operandi Growth Triggers Products Contract Mfg • Target ₹ 50-100 cr revenue • Offer attractive and cost- • Dedicated R&D Team • Diversification & expansion into per product effective solution • Quick implementation of the new geographies to generate

  8. Slide 8: Financial Overview

    FINANCIAL OVERVIEW 7

  9. Slide 9: Business Updates

    Business Updates  In Q3 FY21, delivered growth in sales and improved profitability substantially  On a year-on-year basis compared to 9 months FY 20, for 9 months FY 21 – o Revenue is up 6% , from ₹ 442.7 cr to ₹ 468.6 cr o Gross margin has improved from 38.5% to 41.7% o EBITDA has more than doubl

  10. Slide 10: Q3 FY21 Financial Performance YoY Analysis

    Q3 FY 21 Financial Performance YoY Analysis (₹ cr) REVENUE GEOGRAPHICAL SPLIT 172.5 151.8 112.9 93.4 13.6% 58.4 59.6 Q3 FY20 Q3 FY21 Q3 FY20 Q3 FY21 International Domestic EBITDA & EBITDA MARGIN 30 .0% CASH PAT, PAT & PAT MARGIN 25 .0% 20 .0% 15.9% 9.1% 15 .0% 27.4 0.0% 19.1 10 .0% 15.6 3.5% 5.0 % -

  11. Slide 11: 9M FY21 Financial Performance YoY Analysis

    9M FY 21 Financial Performance YoY Analysis (₹ cr) REVENUE GEOGRAPHICAL SPLIT 468.7 442.7 281.2 281.4 5.9% 161.4 187.4 9M FY20 9M FY21 9M FY20 9M FY21 International Domestic EBITDA & EBITDA MARGIN 20 .0% CASH PAT, PAT & PAT MARGIN 18 .0% 15.4% 8.2% 16 .0% 1.4% 14 .0% 12 .0% 10 .0% 7.5% 72.2 49.3 8.0

  12. Slide 12: Q3 & 9M Profit & Loss Statement

    Q3 & 9M Profit & Loss Statement Particulars (In ₹ cr) Q3 FY21 Q3 FY20 YoY % Q2 FY21 QoQ % 9M FY21 9M FY20 YoY % FY 20 Revenue 172.5 151.8 13.6% 164.0 5.2% 468.7 442.7 5.9% 549.6 COGS 101.3 101.3 -0.1% 97.8 3.6% 273.4 272.5 0.3% 325 Gross Profit 71.2 50.5 41.2% 66.2 7.6% 195.3 170.3 14.7% 224.4 Gross

  13. Slide 13: Past Performance At a Glance

    PAST PERFORMANCE AT A GLANCE All Figures in ₹ cr REVENUE GEOGRAPHY-WISE REVENUE 700 642.9 600 549.5 500 495.9 411.1 343.1 400 296.3 300 200 100 206.4 231.8 199.6 0 0 FY18 FY19 FY20 FY 18 FY 19 FY20 International Domestic EBITDA PAT 3% 11% 12% 3% 10% 10% 16.6 10% 3% 13.8 2% 2% 64.4 8% 2% 55.8 55.5 6%

  14. Slide 14: Healthy Balance Sheet & Stable Working Capital Cycle

    Healthy Balance Sheet & Stable Working Capital Cycle Leverage Analysis (₹ cr) Working Capital Analysis 1.6 1.0 1.0 48 56 42 39 30 37 -135 -101 -114 74 98 91 -21 -29 117 99 91 -48 FY18 FY19 FY20 FY18 FY19 FY20 Receivable Days Inventory Days Debt Equity Debt/Equity Payable Days NWC Days Return Ratios

  15. Slide 15: Thank You!

    THANK YOU! Vikash Verma/ Nachiket Kale Dr. S. Sriram IR Consultant Chief Financial Officer Contact: + 91 9664009029/ 9920940808 Email – Email – investorhelp@punjabchemicals.com punjabchemicals@dickensonworld.com 14

Punjab Chemicals and Crop Protection — Q3 FY21 Earnings Presentation on 6ix